TC Biopharm (TCBPW) Competitors $0.01 0.00 (-16.86%) As of 02/21/2025 02:43 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesTrends TCBPW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying TC Biopharm stock or one of its competitors? The main competitors of TC Biopharm include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. TC Biopharm vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity 180 Life Sciences (NASDAQ:ATNFW) and TC Biopharm (NASDAQ:TCBPW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations. Which has higher earnings & valuation, ATNFW or TCBPW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ATC Biopharm$2.86MN/AN/AN/AN/A Does the MarketBeat Community believe in ATNFW or TCBPW? 180 Life Sciences and TC Biopharm both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ATC BiopharmN/AN/A Is ATNFW or TCBPW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A TC Biopharm N/A N/A N/A Does the media refer more to ATNFW or TCBPW? In the previous week, 180 Life Sciences had 1 more articles in the media than TC Biopharm. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for TC Biopharm. 180 Life Sciences' average media sentiment score of 1.38 beat TC Biopharm's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Positive TC Biopharm Neutral Summary180 Life Sciences beats TC Biopharm on 2 of the 3 factors compared between the two stocks. Get TC Biopharm News Delivered to You Automatically Sign up to receive the latest news and ratings for TCBPW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TCBPW vs. The Competition Export to ExcelMetricTC BiopharmBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$117.96M$5.84B$9.14BDividend YieldN/A3.69%4.76%3.85%P/E RatioN/A3.2018.2614.95Price / SalesN/A4,826.69434.4770.76Price / CashN/A13.0138.4235.17Price / BookN/A47.077.644.65Net IncomeN/A-$87.82M$3.18B$245.69M7 Day PerformanceN/A0.35%-1.95%-2.68%1 Month PerformanceN/A3.62%-0.23%-2.16%1 Year PerformanceN/A99.12%16.69%12.90% TC Biopharm Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCBPWTC BiopharmN/A$0.01-16.9%N/A-24.3%$0.00$2.86M0.0080Gap DownATNFW180 Life SciencesN/A$0.01-9.8%N/A+51.5%$0.00N/A0.007News CoverageGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.03+7.6%N/A-13.4%$0.00N/A0.002Gap DownAIMDWAinosN/A$0.10-35.3%N/A+138.5%$0.00$40,633.000.0040ALVOWAlvotechN/A$2.36+7.3%N/A-46.2%$0.00$391.87M0.004Gap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.05-7.2%N/A-54.4%$0.00N/A0.004BFRIWBiofronteraN/A$0.06-6.3%N/A+254.1%$0.00$35.36M0.0070High Trading VolumeBTMDWbioteN/A$0.50flatN/A-46.2%$0.00$193.06M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.12+22.4%N/A-92.9%$0.00N/A0.008Gap DownCELUWCelularityN/A$0.07+14.3%N/A+120.8%$0.00$48.20M0.00220Gap Up Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Celularity Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TCBPW) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TC Biopharm (Holdings) Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share TC Biopharm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.